- Home
- OBIO vs EHTH Comparison
OBIO vs EHTH Comparison
Compare OBIO & EHTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OBIO
- EHTH
- Stock Information
- Founded
- OBIO 2017
- EHTH 1997
- Country
- OBIO United States
- EHTH United States
- Employees
- OBIO N/A
- EHTH N/A
- Industry
- OBIO Medicinal Chemicals and Botanical Products
- EHTH Specialty Insurers
- Sector
- OBIO Health Care
- EHTH Finance
- Exchange
- OBIO Nasdaq
- EHTH Nasdaq
- Market Cap
- OBIO 151.3M
- EHTH 176.1M
- IPO Year
- OBIO N/A
- EHTH 2006
- Fundamental
- Price
- OBIO $2.85
- EHTH $5.92
- Analyst Decision
- OBIO Strong Buy
- EHTH Buy
- Analyst Count
- OBIO 5
- EHTH 4
- Target Price
- OBIO $15.00
- EHTH $6.38
- AVG Volume (30 Days)
- OBIO 69.1K
- EHTH 188.3K
- Earning Date
- OBIO 05-12-2025
- EHTH 05-06-2025
- Dividend Yield
- OBIO N/A
- EHTH N/A
- EPS Growth
- OBIO N/A
- EHTH N/A
- EPS
- OBIO N/A
- EHTH N/A
- Revenue
- OBIO $2,638,000.00
- EHTH $532,409,999.00
- Revenue This Year
- OBIO $27.37
- EHTH $1.38
- Revenue Next Year
- OBIO $42.68
- EHTH $8.81
- P/E Ratio
- OBIO N/A
- EHTH N/A
- Revenue Growth
- OBIO N/A
- EHTH 17.56
- 52 Week Low
- OBIO $2.49
- EHTH $3.58
- 52 Week High
- OBIO $8.87
- EHTH $11.36
- Technical
- Relative Strength Index (RSI)
- OBIO 36.86
- EHTH 34.05
- Support Level
- OBIO $2.75
- EHTH $5.69
- Resistance Level
- OBIO $3.26
- EHTH $6.24
- Average True Range (ATR)
- OBIO 0.48
- EHTH 0.41
- MACD
- OBIO -0.01
- EHTH 0.06
- Stochastic Oscillator
- OBIO 16.82
- EHTH 40.41
About OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the global commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.
About EHTH eHealth Inc.
eHealth Inc is a company involved in private health insurance marketplace with a technology and service platform that provides consumer engagement, education and health insurance enrollment solutions. The company operates its business in two segments: Medicare which provides health insurance plans and lesser extent ancillary products such as dental and vision insurance and hospital indemnity plans, to medicare eligible consumers; and Employer and Individual provides individual and family health insurance, and small business health insurance plans and Individual Coverage Health Reimbursement Arrangements. It derives maximum revenue from Medicare Segment. All of the company's revenue is from the United States. It also has a presence in China.